Key result
Iosimenol improves injection time and ease of hand injection vs. iodixanol, especially in 4F catheters.
Why the study?
Achieving adequate vessel opacification during PCI can be challenging when using thin catheters, hand injection, and iso-osmolar contrast media such as iodixanol. This study explored these limitations and the possibility of overcoming them with iosimenol, a novel contrast medium.
Does iosimenol improve flow rate, injection time, and ease of hand and power injection through thin angiography catheters compared with iodixanol?
Does iosimenol improve flow rate, injection time, and ease of hand and power injection through thin angiography catheters compared with iodixanol?
Iosimenol, a lower-viscosity iso-osmolar contrast medium, facilitates easier hand injection and better iodine delivery through thin 4F catheters than iodixanol, potentially benefiting transradial coronary interventions.
Answers are grounded in this paper and cite their sources.
Iosimenol eased hand injection through thin catheters in animals; leaves open translation to clinical transradial angiography.
BACKGROUND: It can be challenging to achieve adequate vessel opacification during percutaneous coronary interventions when using thin catheters, hand injection, and iso-osmolar contrast media (CM) such as iodixanol (Visipaque™). PURPOSE: To explore these limitations and the possibility to overcome them with iosimenol, a novel CM. MATERIAL AND METHODS: Three X-ray contrast media with different concentrations were used in this study. A series of in vitro experiments established the relationship between injection pressure and flow rate in angiography catheters under various conditions. The experiments were conducted with power and hand injections and included a double-blind evaluation of user perception. RESULTS: By using hand injection, it was generally not possible to reach a maximum injection pressure exceeding 50 psi. The time within which volunteers were able to complete the injections, the area under the pressure-time curve (AUC), and assessment of ease of injection all were in favor of iosimenol compared with iodixanol, especially when using the 4F thin catheter. Within the pressure ranges tested, the power injections demonstrated that the amount of iodine delivered at a fixed pressure was strongly related to viscosity but unrelated to iodine concentration. CONCLUSION: There are substantial limitations to the amount of iodine that can be delivered through thin catheters by hand injection when iso-osmolar CM with high viscosity is used. The only viable solution, besides increasing the injection pressure, is to use a CM with lower viscosity, since the cost of increasing the concentration, in terms of increased viscosity and consequent reduction in flow, is too high. Iosimenol, an iso-osmolar CM with lower viscosity than iodixanol might therefore be a better alternative when thinner catheters are preferred, especially when the radial artery is used as the access site.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2015) studied Percutaneous coronary interventions (in vitro catheter experiments). Iosimenol vs. Iodixanol was evaluated on Injection time, area under the pressure-time curve (AUC), ease of injection, and iodine delivery rate. Iosimenol improved injection time, pressure-time AUC, and ease of hand injection (max pressure ≤50 psi) compared with iodixanol, especially in 4F thin catheters.
Synapse has enriched 10 related papers. Consider them for comparative context: